-
Signature
-
Danielle White, Attorney-In-Fact for Tessa M Myers
-
Stock symbol
-
ROK
-
Transactions as of
-
Dec 4, 2024
-
Transactions value $
-
-$74,085
-
Form type
-
4
-
Date filed
-
12/6/2024, 05:03 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
ROK |
Common Stock |
Options Exercise |
$0 |
+787 |
+21.17% |
$0.00 |
4.51K |
Dec 4, 2024 |
Direct |
|
transaction |
ROK |
Common Stock |
Sale |
-$74.1K |
-250 |
-5.55% |
$296.34 |
4.26K |
Dec 5, 2024 |
Direct |
F1, F2 |
holding |
ROK |
Common Stock |
|
|
|
|
|
8.34 |
Dec 4, 2024 |
By Savings Plan |
F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
ROK |
Restricted Stock Units |
Options Exercise |
$0 |
-787 |
-33.32% |
$0.00 |
1.58K |
Dec 4, 2024 |
Common Stock |
787 |
|
Direct |
F4, F5 |
transaction |
ROK |
Employee Stock Option (Right to Buy) |
Award |
$0 |
+7.06K |
|
$0.00 |
7.06K |
Dec 5, 2024 |
Common Stock |
7.06K |
$297.10 |
Direct |
F6, F7 |
transaction |
ROK |
Restricted Stock Units |
Award |
$0 |
+2.22K |
|
$0.00 |
2.22K |
Dec 5, 2024 |
Common Stock |
2.22K |
|
Direct |
F4, F5, F6 |
holding |
ROK |
Common Stock Share Equivalents |
|
|
|
|
|
26.7 |
Dec 4, 2024 |
Common Stock |
26.7 |
|
By nonqualified savings plan |
F8, F9, F10 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: